NDC Compounded Drug 73217-002-15 Tacrolimus

Suspension Ophthalmic

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching Tacrolimus 0.03% Ophth
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 73217-002
NDC Package Code 73217-002-15
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 73217000215
Package Description 15 mL in 1 BOTTLE, DROPPER
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Tacrolimus 0.03% Ophth
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Tacrolimus
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Tacrolimus
Usage Information Product Usage Information
The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs.		 Tacrolimus is used with other medications to prevent rejection of a kidney transplant. This medication belongs to a class of drugs known as immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.
Dosage Form Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Route Name Ophthalmic - Administration to the external eye.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 73217
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Stokes Healthcare
Substance Name Tacrolimus
Active Ingredients Information .3 mg/1 mL
Reporting Period 2023-2

NDC Crossover Products Matching Tacrolimus

NDC crossover of Tacrolimus 0.03% Ophth with NDC 73217-002 a human compounded drug with other similar products matching the same substance name (Tacrolimus) and the same administration route (ophthalmic) or dosage form (suspension).

Frequently Asked Questions

What is the NDC number assigned to Tacrolimus 0.3% Ophth?

Tacrolimus 0.3% Ophth was assigned by its manufacturer with NDC product code 73217-002. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Tacrolimus 0.3% Ophth?

The NDC package code 73217-002-15 was assigned to a 15 mL in 1 BOTTLE, DROPPER of tacrolimus administered ophthalmic via suspension.

Who manufactures this product?

Tacrolimus 0.3% Ophth is manufactured by an outsourced facility and labeled by Stokes Healthcare. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 25 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Stokes Healthcare with NDC product codes 73217-001-10, 73217-001-10, 73217-001-10, 73217-001-10, 73217-001-15, 73217-001-15, 73217-001-15, 73217-001-15, 73217-002-10, 73217-002-10, 73217-002-10, 73217-002-10, 73217-003-10, 73217-003-10, 73217-003-10, 73217-004-10, 73217-004-10, 73217-004-10, 73217-004-10, 73217-005-10, 73217-005-10, 73217-005-10, 73217-005-10, 73217-007-10 and 73217-007-10.